Mechanisms of deoxynivalenol-induced gene expression and apoptosis

Food Additives and Contaminants - Part A

Volumn 25, Issue 9, 2008, Pages 1128-1140

  Pestka, J J ^a  

^a Michigan State University ^*  (United States)

Author keywords

Fusarium; Immunotoxicity; Mycotoxin; Trichothecene

Indexed keywords

CYCLOOXYGENASE 2; DOUBLE STRANDED RNA; HEMATOPOIETIC CELL KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TRICHOTHECENE; VOMITOXIN;

ABDOMINAL DISEASE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BINDING SITE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIARRHEA; DOWN REGULATION; EXPOSURE; FOOD CONTAMINATION; FUSARIUM; GENE ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; MACROPHAGE; MALAISE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RIBOSOME; RNA STABILITY; SALIVATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION; VOMITING;

ANIMALIA; FUSARIUM; HORDEUM; TRITICUM AESTIVUM; ZEA MAYS;

ANIMALS; APOPTOSIS; EATING; FOOD CONTAMINATION; GENE EXPRESSION REGULATION; GROWTH; HUMANS; IMMUNE SYSTEM PROCESSES; LEUKOCYTES; MYCOTOXINS; TRICHOTHECENES; UP-REGULATION;

EID: 70849100264     PISSN: 19440049     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/02652030802056626     Document Type: Article

References (134)

1. Abbas HK, Mirocha CJ, Tuite J. 1986. Natural occurrence of deoxynivalenol, 15-acetyl-deoxynivalenol, and zearalenone in refusal factor corn stored since 1972. Appl Environ Microbiol. 51:841-843.
2. Abouzied MM, Azcona JI, Braselton WE, Pestka JJ. 1991. Immunochemical assessment of mycotoxins in 1989 grain foods: evidence for deoxynivalenol (vomitoxin) contamination. Appl Environ Microbiol. 57:672-677.
3. Arnold DL, McGuire PF, Nera EA, Karpinski KF, Bickis MG, Zawidzka ZZ, Fernie S, Vesonder RF. 1986. The toxicity of orally administered deoxynivalenol (vomitoxin) in rats and mice. Food Chem Toxicol. 24:935-941.
4. Atkinson HA, Miller K. 1984. Inhibitory effect of deox-ynivalenol, 3-acetyldeoxynivalenol and zearalenone on induction of rat and human lymphocyte proliferation. Toxicol Lett. 23:215-221.
5. Azcona-Olivera JI, Ouyang YL, Warner RL, Linz JE, Pestka JJ. 1995c. Effects of vomitoxin (deoxynivalenol) and cycloheximide on IL-2, 4, 5 and 6 secretion and mRNA levels in murine CD4+ cells. Food Chem Toxicol. 33:433-441.
6. Azcona-Olivera JI, Ouyang Y, Murtha J, Chu FS, Pestka JJ. 1995a. Induction of cytokine mRNAs in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): relationship to toxin distribution and protein synthesis inhibition. Toxicol Appl Pharmacol. 133:109-120.
7. Azcona-Olivera JI, Ouyang Y, Murtha J, Chu FS, Pestka JJ. 1995b. Induction of cytokine mRNAs in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): relationship to toxin distribution and protein synthesis inhibition. Toxicol Appl Pharmacol. 133:109-120.
8. Bae HK, Pestka JJ. 2006. Protein kinases associate ribosomes during the deoxynivalenol-induced ribotoxic stress response in the macrophage. Toxicologist. 90:206.
9. Bergsjo B, Matre T, Nafstad I. 1992. Effects of diets with graded levels of deoxynivalenol on performance in growing pigs. Zentralbl Veterinarmed. [A]. 39:752-758.
10. Bhat RV, Beedu SR, Ramakrishna Y, Munshi KL. 1989. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet i(8628):35-37.
11. Bondy GS, Pestka JJ. 1991. Dietary exposure to the trichothecene vomitoxin (deoxynivalenol) stimulates term- inal differentiation of Peyer's patch B cells to IgA secreting plasma cells. Toxicol Appl Pharmacol. 108:520-530.
12. Bondy GS, McCormick SP, Beremand MN, Pestka JJ. 1991. Murine lymphocyte proliferation impaired by substituted neosolaniols and calonectrins - Fusarium metabolites associated with trichothecene biosynthesis. Toxicon. 29:1107-1113.
13. Carter CJ, Cannon M. 1977. Structural requirements for the inhibitory action of 12,13-epoxytrichothecenes on protein synthesis in eukaryotes. Biochem J. 166: 399-409.
14. Chung YJ, Yang GH, Islam Z, Pestka JJ. 2003. Up-regulation of macrophage inflammatory protein-2 and complement 3A receptor by the trichothecenes deoxynivalenol and satratoxin G. Toxicology. 186:51-65.
15. Chung YJ, Zhou HR, Pestka JJ. 2003. Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-alpha expression by deoxynivalenol (vomitoxin). Toxicol Appl Pharmacol. 193:188-201.
16. Cobb MH. 1999. MAP kinase pathways. Prog Biophys Mol Biol. 71:479-500.
17. Cooray R. 1984. Effects of some mycotoxins on mitogen- induced blastogenesis and SCE frequency in human lymphocytes. Food Chem Toxicol. 22:529-534.
18. Der SD, Yang YL, Weissmann C, Williams BR. 1997. A double-stranded RNA-activated protein kinase-depen-dent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci USA. 94:3279-3283.
19. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. 2000. Post-transcriptional control of cycloox-ygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem. 275:11750-11757.
20. Dong C, Davis RJ, Flavell RA. 2002. MAP kinases in the immune response. Annu Rev Immunol. 20:55-72.
21. Dong W, Pestka JJ. 1993. Persistent dysregulation of IgA production and IgA nephropathy in the B6C3F1 mouse following withdrawal of dietary vomitoxin (deoxynivalenol). Fundam Appl Toxicol. 20:38-47.
22. Dong W, Sell JE, Pestka JJ. 1991. Quantitative assessment of mesangial immunoglobulin A (IgA) accumulation, ele-vated circulating IgA immune complexes, and hematuria during vomitoxin-induced IgA nephropathy. Fundam Appl Toxic Off J Soc Toxicol. 17:197-207.
23. Ernst M, Inglese M, Scholz GM, Harder KW, Clay FJ, Bozinovski S, Waring P, Darwiche R, Kay T, Sly P, et al. 2002. Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response. J Exp Med. 196:589-604.
24. Forsell JH, Kateley JR, Yoshizawa T, Pestka JJ. 1985. Inhibition of mitogen-induced blastogenesis in human lymphocytes by T-2 toxin and its metabolites. Appl Environ Microbial. 49:1523-1526.
25. Forsell JH, Jensen R, Tai JH, Witt M, Lin WS, Pestka JJ. 1987. Comparison of acute toxicities of deoxynivalenol (vomitoxin) and 15-acetyldeoxynivalenol in the B6C3F1 mouse. Food Chem Toxicol. 25:155-162.
26. Forsell JH, Pestka JJ. 1985. Relation of 8-ketotrichothecene and zearalenone analog structure to inhibition of mitogen-induced human lymphocyte blastogenesis. Appl Environ Microbiol. 50:1304-1307.
27. Forsell JH, Witt MF, Tai JH, Jensen R, Pestka JJ. 1986. Effects of 8-week exposure of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone. Food Chem Toxicol. 24:213-219.
28. Forsyth DM, Yoshizawa T, Morooka N, Tuite J. 1977. Emetic and refusal activity of deoxynivalenol to swine. Appl Environ Microbiol. 34:547-552.
29. Friend DW, Trenholm HL, Elliot JI, Thompson BK, Hartin KE. 1982. Effect of feeding vomitoxin-contaminated wheat to pigs. Can J Anim Sci. 62:1211-1222.
30. Friend SC, Babiuk LA, Schiefer HB. 1983. The effects of dietary T-2 toxin on the immunological function and herpes simplex reactivation in Swiss mice. Toxicol Appl Pharmacol. 69:234-244.
31. Goh KC, deVeer MJ, Williams BR. 2000. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 19:4292-4297.
32. Gray JS, Pestka JJ. 2007. Transcriptional regulation of deoxynivalenol-induced IL-8 expression in human mono-cytes. Toxicol Sci. 99:502-511.
33. Greene DM, Azcona Olivera JI, Pestka JJ. 1994. Vomitoxin (deoxynivalenol)-induced IgA nephropathy in the B6C3F1 mouse: dose response and male predilection. Toxicology. 92:245-260.
34. Greene DM, Azcona Olivera JI, Murtha JM, Pestka JJ. 1995. Effects of dihydrotestosterone and estradiol on experimental IgA nephropathy induced by vomitoxin. Fundam Appl Toxicol. 26:107-116.
35. Greene DM, Bondy GS, Azcona Olivera JI, Pestka JJ. 1994. Role of gender and strain in vomitoxin-induced dysregula- tion of IgA production and IgA nephropathy in the mouse. J Toxicol Environ Health. 43:37-50.
36. Groopman JD, Johnson D, Kensler TW. 2005. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk. Cancer Biomark. 1:5-14.
37. Grove JF. 1988. Non-macrocyclic trichothecenes. Nat Prod Rep. 5:187-209.
38. Grove JF. 1993. Macrocyclic trichothecenes. Nat Prod Rep. 10:429-448.
39. Grove JF. 2000. Non-macrocyclic trichothecenes Part 2. Prog Chem Org Nat Prod. 69:1-70.
40. Hughes BJ, Hsieh GC, Jarvis BB, Sharma RP. 1989. Effects of macrocyclic trichothecene mycotoxins on the murine immune system. Arch Environ Contam Toxicol. 18:388-395.
41. Hughes BJ, Jarvis BB, Sharma RP. 1990. Effects of macrocyclic trichothecene congeners on the viability and mitogenesis of murine splenic lymphocytes. Toxicol Lett. 50:57-67.
42. Hughes BJ, Taylor MJ, Sharma RP. 1988. Effects of verrucarin A and roridin A, macrocyclic trichothecene mycotoxins, on the murine immune system. Immunopharmacology. 16:79-87.
43. Hughes DM, Gahl MJ, Graham CH, Grieb SL. 1999. Overt signs of toxicity to dogs and cats of dietary deoxynivalenol. J Anim Sci. 77:693-700.
44. Hunder G, Schumann K, Strugala G, Gropp J, Fichtl B, Forth W. 1991. Influence of subchronic exposure to low dietary deoxynivalenol, a trichothecene mycotoxin, on intestinal absorption of nutrients in mice. Food Chem Toxicol. 29:809-814.
45. Ihara T, Sugamata M, Sekijima M, Okumura H, Yoshino N, Ueno Y. 1997. Apoptotic cellular damage in mice after T-2 toxin-induced acute toxicosis. Nat Toxins. 5:141-145.
46. Ihara T, Yamamoto T, Sugamata M, Okumura H, Ueno Y. 1998. The process of ultrastructural changes from nuclei to apoptotic body. Virchows Arch. 433:443-447.
47. Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, Chen SL, Magun BE. 1997. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol Cell Biol. 17:3373-3381.
48. Islam Z, Gray JS, Pestka JJ. 2006. p38 Mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes. Toxicol Appl Pharmacol. 213:235-244.
49. Islam Z, Nagase M, Yoshizawa T, Yamauchi K, Sakato N. 1998a. T-2 toxin induces thymic apoptosis in vivo in mice. Toxicol Appl Pharmacol. 148:205-214.
50. Islam Z, Nagase M, Yoshizawa T, Yamauchi K, Sakato N. 1998b. T-2 toxin induces thymic apoptosis in vivo in mice. Toxicol Appl Pharmacol. 148:205-214.
51. Iverson F, Armstrong C, Nera E, Truelove J, Fernie S, Scott P, Stapley R, Hayward S, Gunner S. 1995. Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratog Carcinog Mutagen. 15:283-306.
52. Jia Q, Zhou HR, Shi Y, Pestka JJ. 2006. Docosahexaenoic acid consumption inhibits deoxynivalenol-induced CREB/ ATF1 activation and IL-6 gene transcription in mouse macrophages. J Nutr. 136:366-372.
53. Joffe AZ. 1978. Fusarium poae and F. sporotichiodes as principal causal agents of alimentary toxic aleukia. In: Wyllie TD, Morehouse LG, editors. Mycotoxic fungi, mycotoxins, mycotoxicoses: an encylcopedic handbook. New York (NY): Dekker. p. 21-86.
54. Kanra GY, Ozen H, Kara A. 2006. Infection and anorexia. Turk J Pediatr. 48:279-287.
55. Kinser S, Jia Q, Li M, Laughter A, Cornwell P, Corton JC, Pestka J. 2004. Gene expression profiling in spleens of deoxynivalenol-exposed mice: immediate early genes as primary targets. J Toxicol Environ Health A. 67:1423-1441.
56. Laskin JD, Heck DE, Laskin DL. 2002. The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity. Toxicol Sci. 69:289-291.
57. Le DG, Auffret M, Batina P, Arnold F, Sibiril Y, Arzur D, Parent-Massin D. 2005. Myelotoxicity of trichothecenes and apoptosis: an in vitro study on human cord blood CD34{thorn} hematopoietic progenitor. Toxicol In Vitro. 19:1015-1024.
58. Lee US, Jang HS, Tanaka T, Hasegawa A, Oh YJ, Ueno Y. 1985. The coexistence of the Fusarium mycotoxins nivale- nol, deoxynivalenol and zearalenone in Korean cereals harvested in 1983. Food Addit Contam. 2:185-192.
59. Li G, Shinozuka J, Uetsuka K, Nakayama H, Doi K. 1997. T-2 toxin-induced apoptosis in intestinal crypt epithelial cells of mice. Exp Toxicol Pathol. 49:447-450.
60. Li J, Shimizu T, Miyoshi N, Yasuda N. 1997. Rapid apoptotic changes in the gastric glandular epithelium of rats administered intraperitoneally with fusarenon-X. J Vet Med Sci. 59:17-22.
61. Li S, Ouyang YL, Dong W, Pestka JJ. 1997. Superinduction of IL-2 gene expression by vomitoxin (deoxynivalenol) involves increased mRNA stability. Toxicol Appl Pharmacol. 147:331-342.
62. Li S, Ouyang Y, Yang GH, Pestka JJ. 2000. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol). Toxicol Appl Pharmacol. 163:17-25.
63. Luo X. 1994. Food poisoning caused by Fusarium toxins. In Proceedings of the Second Asian Conference on Food Safety. ILSI, Thailand. p. 129-136.
64. McMullen M, Jones R, Gallenberg D. 1997. Scab of wheat and barley: a re-emerging disease of devasting impact. Plant Dis. 81:1340-1348.
65. Meusel TR, Kehoe KE, Imani F. 2002. Protein kinase R regulates double-stranded RNA induction of TNF-alpha but not IL-1 beta mRNA in human epithelial cells. J Immunol. 168:6429-6435.
66. Miller K, Atkinson HA. 1986. The in vitro effects of trichothecenes on the immune system. Food Chem Toxicol. 24:545-549.
67. Miller K, Atkinson HA. 1987. The in vitro effects of trichothecenes on the immune system. Arch Toxicol. Suppl. 11:321-324.
68. Miura K, Nakajima Y, Yamanaka N, Terao K, Shibato T, Ishino S. 1998. Induction of apoptosis with fusarenon-X in mouse thymocytes. Toxicology. 127:195-206.
69. Moon Y, Pestka JJ. 2002. Vomitoxin-induced cyclooxygen-ase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. Toxicol Sci. 69:373-382.
70. Moon Y, Pestka JJ. 2003a. Cyclooxygenase-2 mediates interleukin-6 upregulation by vomitoxin (deoxynivalenol) in vitro and in vivo. Toxicol Appl Pharmacol. 187:80-88.
71. Moon Y, Pestka JJ. 2003b. Deoxynivalenol-induced mito-gen-activated protein kinase phosphorylation and IL-6 expression in mice suppressed by fish oil. J Nutr Biochem. 14:717-726.
72. Moon Y, Uzarski R, Pestka JJ. 2003. Relationship of trichothecene structure to COX-2 induction in the macro- phage: selective action of type B (8-keto) trichothecenes. J Toxicol Environ Health A. 66:1967-1983.
73. Ouyang YL, Azcona Olivera JI, Murtha J, Pestka JJ. 1996. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4{thorn} T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation. Toxicol Appl Pharmacol. 138:324-334.
74. Ouyang YL, Li S, Pestka JJ. 1996. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells. Toxicol Appl Pharmacol. 140:328-336.
75. Parent-Massin D. 2004. Haematotoxicity of trichothecenes. Toxicol Lett. 153:75-81.
76. Pestka JJ. 2003. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol Lett. 140-141:287-295.
77. Pestka JJ, Azcona Olivera JI, Plattner RD, Minervini F, Doko MB, Visconti A. 1994. Comparative assessment of fumonisin in grain-based foods by ELISA, GC-MS, and HPLC. J Food Prot. 57:169-172.
78. Pestka JJ, Dong W, Warner RL, Rasooly L, Bondy GS, Brooks KH. 1990. Elevated membrane IgA+ and CD4+ (T helper) populations in murine Peyer's patch and splenic lymphocytes during dietary administration of the tri- chothecene vomitoxin (deoxynivalenol). Food Chem Toxicol. 28:409-420.
79. Pestka JJ, Dong W, Warner RL, Rasooly L, Bondy GS. 1990. Effect of dietary administration of the trichothecene vomitoxin (deoxynivalenol) on IgA and IgG secretion by Peyer's patch and splenic lymphocytes. Food Chem Toxicol. 28:693-699.
80. Pestka JJ, Forsell JH. 1988. Inhibition of human lymphocyte transformation by the macrocyclic trichothecenes roridin A and verrucarin A. Toxicol Lett. 41:215-222.
81. Pestka JJ, Lin WS, Miller ER. 1987. Emetic activity of the trichothecene 15-acetyldeoxynivalenol in swine. Food Chem Toxicol. 25:855-858.
82. Pestka JJ, Moorman MA, Warner RL. 1989. Dysregulation of IgA production and IgA nephropathy induced by the trichothecene vomitoxin. Food Chem Toxicol. 27:361-368.
83. Pestka JJ, Moorman MA, Warner RL. 1990. Altered serum immunoglobulin response to model intestinal antigens during dietary exposure to vomitoxin (deoxynivalenol). Toxicol Lett. 50:75-84.
84. Pestka JJ, Smolinski AT. 2005. Deoxynivalenol: toxicology and potential effects on humans. J Toxicol Environ Health B Crit Rev. 8:39-69.
85. Pestka JJ, Tai JH, Witt MF, Dixon DE, Forsell JH. 1987. Suppression of immune response in the B6C3F1 mouse after dietary exposure to the Fusarium mycotoxins deoxynivalenol (vomitoxin) and zearalenone. Food Chem Toxicol. 25:297-304.
86. Pestka JJ, Yan D, King LE. 1994. Flow cytometric analysis of the effects of in vitro exposure to vomitoxin (deox- ynivalenol) on apoptosis in murine T, B and IgA{thorn} cells. Food Chem Toxicol. 32:1125-1136.
87. Pestka JJ, Zhou HR, Moon Y, Chung YJ. 2004. Cellular and molecular mechanisms for immune modulation by deox- ynivalenol and other trichothecenes: unraveling a paradox. Toxicol Lett. 153:61-73.
88. Pestka JJ, Zhou HR. 2000. Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (deoxynivalenol) ingestion. Food Chem Toxicol. 38:565-575.
89. Pestka J, Zhou HR. 2003. Hck-and PKR-dependent mitogen-activated protein kinase phosphorylation and AP-1, C/EBP and NF-kB activation precendes deoxyni-valenol-induced TNF- and MIP-2 expression. Toxicologist. 72:121.
90. Prelusky DB, Trenholm HL. 1993. The efficacy of various classes of anti-emetics in preventing deoxynivalenol-induced vomiting in swine. Nat Toxins. 1:296-302.
91. Prelusky DB, Gerdes RG, Underhill KL, Rotter BA, Jui PY, Trenholm HL. 1994. Effects of low-level dietary deoxyni- valenol on haematological and clinical parameters of the pig. Nat Toxins. 2:97-104.
92. Rasooly L, Abouzied MM, Brooks KH, Pestka JJ. 1994. Polyspecific and autoreactive IgA secreted by hybridomas derived from Peyer's patches of vomitoxin-fed mice: characterization and possible pathogenic role in IgA nephropathy. Food Chem Toxicol. 32:337-348.
93. Rasooly L, Pestka JJ. 1992. Vomitoxin-induced dysregulation of serum IgA, IgM and IgG reactive with gut bacterial and self antigens. Food Chem Toxicol. 30:499-504.
94. Rasooly L, Pestka JJ. 1994. Polyclonal autoreactive IgA increase and mesangial deposition during vomitoxin-induced IgA nephropahty in the BALB/c mouse. Food Chem Toxicol. 32:329-336.
95. Robbana-Barnat S, Loridon-Rosa B, Cohen H, Lafarge-Frayssinet C, Neish GA, Frayssinet C. 1987. Protein synthesis inhibition and cardiac lesions associated with deoxynivalenol ingestion in mice. Food Addit Contam. 4:49-56.
96. Rotter BA, Prelusky DB, Pestka JJ. 1996. Toxicology of deoxynivalenol (vomitoxin). J Toxicol Environ Health. 48:1-34.
97. Rotter BA, Thompson BK, Lessard M, Trenholm HL, Tryphonas H. 1994. Influence of low-level exposure to Fusarium mycotoxins on selected immunological and hematological parameters in young swine. Fundam Appl Toxicol. 23:117-124.
98. Schaeffer HJ, Weber MJ. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol. 19:2435-2444.
99. Schwartz GJ. 2002. Neural-immune gut-brain communica- tion in the anorexia of disease. Nutrition. 18:528-533.
100. Shifrin VI, Anderson P. 1999. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem. 274: 13985-13992.
101. Shinozuka J, Guanmin L, Uetsuka K, Nakayama H, Doi K. 1997. Process of the development of T-2 toxin-induced apoptosis in the lymphoid organs of mice. Exp Anim. 46:117-126.
102. Shinozuka J, Li G, Kiatipattanasakul W, Uetsuka K, Nakayama H, Doi K. 1997. T-2 toxin-induced apoptosis in lymphoid organs of mice. Exp Toxicol Pathol. 49:387-392.
103. Shinozuka J, Suzuki M, Noguchi N, Sugimoto T, Uetsuka K, Nakayama H, Doi K. 1998. T-2 toxin-induced apoptosis in hematopoietic tissues of mice. Toxicol Pathol. 26:674-681.
104. Smith WL, DeWitt DL, Garavito RM. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 69:145-182.
105. Sugiura Y, Watanabe Y, Tanaka T, Yamamoto S, Ueno Y. 1990. Occurrence of Gibberella zeae strains that produce both nivalenol and deoxynivalenol. Appl Environ Microbiol. 56:3047-3051.
106. Tanaka T, Yamamoto S, Hasegawa A, Aoki N, Besling JR, Sugiura Y, Ueno Y. 1990. A survey of the natural occurrence of Fusarium mycotoxins, deoxynivalenol, nivalenol and zearalenone, in cereals harvested in the Netherlands. Mycopathologia. 110:19-22.
107. Tomar RS, Blakley BR, DeCoteau WE. 1987. Immunological responsiveness of mouse spleen cells after in vivo or in vitro exposure to 3-acetyldeoxynivalenol. Food Chem Toxicol. 25:393-398.
108. Tomar RS, Blakley BR, De Coteau WE. 1988. In vitro effects of T-2 toxin on the mitogen responsiveness and antibody-producing ability of human lymphocytes. Toxicol Lett. 40:109-117.
109. Tomar RS, Blakley BR, Schiefer HB, DeCoteau WE. 1986. In vitro effects of 3-acetyl-deoxynivalenol on the immune response of human peripheral blood lymphocytes. Int J Immunopharmacol. 8:125-130.
110. Trenholm HL, Hamilton RM, Friend DW, Thompson BK, Hartin KE. 1984. Feeding trials with vomitoxin (deox- ynivalenol)-contaminated wheat: effects on swine, poultry, and dairy cattle. J Am Vet Med Assoc. 185:527-531.
111. Tsygankov AY. 2003. Non-receptor protein tyrosine kinases. Front Biosci. 8, s595-s635.
112. Ueno Y. 1984. Toxicological features of T-2 toxin and related trichothecenes. Fundam Appl Toxicol. 4:S124-S132.
113. Warner RL, Brooks K, Pestka JJ. 1994. In vitro effects of vomitoxin (deoxynivalenol) on lymphocyte function: enhanced interleukin production and help for IgA secre- tion. Food Chem Toxicol. 32:617-625.
114. Widmann C, Gibson S, Jarpe MB, Johnson GL. 1999. Mitogen-activated protein kinase: conservation of a three- kinase module from yeast to human. Physiol Rev. 79:143-180.
115. Williams BR. 2001. Signal integration via PKR. Sci. STKE 89:RE2.
116. Wong SS, Zhou HR, Pestka JJ. 2002. Effects of vomitoxin (deoxynivalenol) on the binding of transcription factors AP-1, NF-kappaB, and NF-IL6 in raw 264.7 macrophage cells. J Toxicol Environ Health A. 65:1161-1180.
117. Wong SS, Zhou HR, Marin-Martinez ML, Brooks K, Pestka JJ. 1998. Modulation of IL-1beta, IL-6 and TNF-alpha secretion and mRNA expression by the trichothe- cene vomitoxin in the RAW 264.7 murine macrophage cell line. Food Chem Toxicol. 36:409-419.
118. Yan D, Zhou HR, Brooks KH, Pestka JJ. 1997. Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer's patch cells isolated from mice acutely exposed to vomitoxin. Toxicology. 122:145-158.
119. Yan D, Zhou HR, Brooks KH, Pestka JJ. 1998. Role of macrophages in elevated IgA and IL-6 production by Peyer's patch cultures following acute oral vomitoxin exposure. Toxicol Appl Pharmacol. 148:261-273.
120. Yang G, Jarvis BB, Chung Y, Pestka JJ. 2000. Apoptosis induction by the satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK and SAPK/JNK Activation. Toxicol Appl Pharmacol. 164:149-160.
121. Yeung MC, Liu J, Lau AS. 1996. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc Natl Acad Sci USA. 93:12451-12455.
122. Yoshizawa T. 1983. Red-mold disease and natural occurrence in Japan. In: Ueno, Y, editor. Trichothecenes: chemical, biological and toxicological aspects (Developments in Food Science). New York: Elsevier p. 195-209.
123. Yoshizawa T, Morooka N. 1977. Trichothecenes in mold infested cereals in Japan. In: Rodricks JV, Hesseltine CW, Mehlman MA, editors. Mycotoxins in human and animal health. Park Forest South (IL): Pathotox. p. 309-321.
124. Yoshizawa T, Takeda H, Ohim T. 1983. Structure of a novel metabolite from deoxynivalenol, a trichothecene mycotoxin, in animals. Agric Biol Chem. 47:2133-2135.
125. Young LG, McGirr L, Valli VE, Lumsden JH, Lun A. 1983. Vomitoxin in corn fed to young pigs. J Anim Sci. 57:655-664.
126. Zhou HR, Pestka JJ. 2003. Deoxynivalenol-induced apoptosis mediated by p38 MAPK-dependent p53 gene induction in RAW 264.7 macrophages. Toxicologist. 72:330.
127. Zhou HR, Pestka JJ. 2005. Induction of competing apoptotic and survival signaling pathways in the macro-phage by the ribotoxic trichothecene deoxynivalenol. Toxicol Sci. 87:113-122.
128. Zhou HR, Harkema JR, Yan D, Pestka JJ. 1999. Amplified proinflammatory cytokine expression and toxicity in mice coexposed to lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol). J Toxicol Environ Health. 57:115-136.
129. Zhou HR, Islam Z, Pestka JJ. 2003. Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cyto-kine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin. Toxicol Sci. 72:130-142.
130. Zhou HR, Islam Z, Pestka JJ. 2005. Induction of competing apoptotic and survival signaling pathways in the macrophage by the ribotoxic trichothecene deoxynivalenol. Toxicol Sci. 87:113-122.
131. Zhou HR, Jia Q, Pestka JJ. 2005. Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck. Toxicol Sci. 85:916-926.
132. Zhou HR, Lau AS, Pestka JJ. 2003. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response. Toxicol Sci. 74:61-73.
133. Zhou HR, Yan D, Pestka JJ. 1997. Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): dose response and time course. Toxicol Appl Pharmacol. 144:294-305.
134. Zhou HR, Yan D, Pestka JJ. 1998. Induction of cytokine gene expression in mice after repeated and subchronic oral exposure to vomitoxin (deoxynivalenol): differential toxin-induced hyporesponsiveness and recovery. Toxicol Appl Pharmacol. 151:347-358.